Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet/streptozotocin-induced diabetic rats

PaperCitations, authors & open-access status

Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet/streptozotocin-induced diabetic rats is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 295 citations, 2019 year and gold oa status.

295
Citations
2019
Year
gold
OA Status

Related on ScholarIQ

Zhiwei Zhang
Author
Cardiovascular Diabetology
Journal
Atrial Fibrillation Management and Outcomes
Topic
Atrial Fibrillation Management and Outcomes
Topic
Cardiovascular Function and Risk Factors
Topic
Diabetes Treatment and Management
Topic
470M+ articles · free account